Rare diseases
Investigational molecules
Locations
8 F, Lane 221, No 41 Gangqian Rd, 11494
Twi Biotechnology Inc. is involved in clinical research focused on generalized epidermolysis bullosa simplex, a rare inherited blistering skin disorder affecting both adult and pediatric patients.
The company’s research interest centers on conditions marked by fragile skin and recurrent blistering, with attention to severe and intermediate disease forms.
Twi Biotechnology Inc. runs clinical trials in conditions such as Epidermolysis bullosa, among others.
Clinical trials run by this sponsor – those enrolling participants first.
AustriaIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
